Select Medical (SEM) Competitors

$33.95
-0.27 (-0.79%)
(As of 05/17/2024 ET)

SEM vs. EHC, IMVT, ALPN, DOCS, MDGL, TMDX, NUVL, KRYS, RDNT, and INSP

Should you be buying Select Medical stock or one of its competitors? The main competitors of Select Medical include Encompass Health (EHC), Immunovant (IMVT), Alpine Immune Sciences (ALPN), Doximity (DOCS), Madrigal Pharmaceuticals (MDGL), TransMedics Group (TMDX), Nuvalent (NUVL), Krystal Biotech (KRYS), RadNet (RDNT), and Inspire Medical Systems (INSP). These companies are all part of the "medical" sector.

Select Medical vs.

Select Medical (NYSE:SEM) and Encompass Health (NYSE:EHC) are both mid-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, analyst recommendations, valuation, earnings, risk, institutional ownership, community ranking, profitability and media sentiment.

Encompass Health has lower revenue, but higher earnings than Select Medical. Select Medical is trading at a lower price-to-earnings ratio than Encompass Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Select Medical$6.66B0.66$243.49M$2.1016.17
Encompass Health$4.80B1.79$352M$3.7023.09

Encompass Health received 159 more outperform votes than Select Medical when rated by MarketBeat users. Likewise, 71.83% of users gave Encompass Health an outperform vote while only 57.85% of users gave Select Medical an outperform vote.

CompanyUnderperformOutperform
Select MedicalOutperform Votes
328
57.85%
Underperform Votes
239
42.15%
Encompass HealthOutperform Votes
487
71.83%
Underperform Votes
191
28.17%

Select Medical has a beta of 1.38, suggesting that its share price is 38% more volatile than the S&P 500. Comparatively, Encompass Health has a beta of 0.92, suggesting that its share price is 8% less volatile than the S&P 500.

Select Medical currently has a consensus price target of $34.25, indicating a potential upside of 0.88%. Encompass Health has a consensus price target of $90.29, indicating a potential upside of 5.66%. Given Encompass Health's stronger consensus rating and higher probable upside, analysts clearly believe Encompass Health is more favorable than Select Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Select Medical
0 Sell rating(s)
2 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.50
Encompass Health
0 Sell rating(s)
0 Hold rating(s)
7 Buy rating(s)
1 Strong Buy rating(s)
3.13

Encompass Health has a net margin of 7.60% compared to Select Medical's net margin of 3.97%. Select Medical's return on equity of 18.11% beat Encompass Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Select Medical3.97% 18.11% 3.64%
Encompass Health 7.60%18.01%6.55%

In the previous week, Encompass Health had 2 more articles in the media than Select Medical. MarketBeat recorded 10 mentions for Encompass Health and 8 mentions for Select Medical. Encompass Health's average media sentiment score of 0.87 beat Select Medical's score of 0.62 indicating that Encompass Health is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Select Medical
4 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Encompass Health
6 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

89.5% of Select Medical shares are owned by institutional investors. Comparatively, 97.3% of Encompass Health shares are owned by institutional investors. 19.1% of Select Medical shares are owned by company insiders. Comparatively, 2.1% of Encompass Health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Select Medical pays an annual dividend of $0.50 per share and has a dividend yield of 1.5%. Encompass Health pays an annual dividend of $0.60 per share and has a dividend yield of 0.7%. Select Medical pays out 23.8% of its earnings in the form of a dividend. Encompass Health pays out 16.2% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Summary

Encompass Health beats Select Medical on 16 of the 21 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SEM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SEM vs. The Competition

MetricSelect MedicalHospitals IndustryMedical SectorNYSE Exchange
Market Cap$4.41B$4.56B$5.31B$18.07B
Dividend Yield1.46%1.08%43.94%3.44%
P/E Ratio16.1713.09151.1626.21
Price / Sales0.660.932,354.9511.64
Price / Cash9.449.1836.7319.45
Price / Book2.702.375.746.01
Net Income$243.49M$178.36M$106.98M$966.65M
7 Day Performance1.07%-2.01%1.41%1.85%
1 Month Performance25.46%6.35%4.94%6.59%
1 Year Performance19.12%4.70%7.83%23.69%

Select Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
EHC
Encompass Health
4.7552 of 5 stars
$86.87
+0.8%
$90.29
+3.9%
+38.9%$8.75B$4.80B23.4838,000
IMVT
Immunovant
1.581 of 5 stars
$30.48
+2.0%
$48.00
+57.5%
+44.6%$4.43BN/A-16.57164Short Interest ↑
Positive News
ALPN
Alpine Immune Sciences
1.923 of 5 stars
$64.95
flat
$50.33
-22.5%
+655.5%$4.46B$58.88M-101.48142Analyst Forecast
News Coverage
Positive News
DOCS
Doximity
2.9664 of 5 stars
$23.51
+2.3%
$28.82
+22.6%
-15.9%$4.38B$419.05M35.61977Analyst Forecast
Options Volume
News Coverage
Gap Up
MDGL
Madrigal Pharmaceuticals
4.4688 of 5 stars
$210.98
-0.2%
$345.09
+63.6%
-20.4%$4.50BN/A-9.14376Insider Selling
TMDX
TransMedics Group
2.7311 of 5 stars
$132.44
+0.3%
$119.00
-10.1%
+87.8%$4.36B$241.62M-389.53584Insider Selling
NUVL
Nuvalent
2.9307 of 5 stars
$68.02
+2.9%
$90.78
+33.5%
+82.1%$4.36BN/A-28.2292Analyst Forecast
Insider Selling
News Coverage
KRYS
Krystal Biotech
4.5882 of 5 stars
$159.47
+3.0%
$171.00
+7.2%
+87.7%$4.55B$95.95M85.28229Short Interest ↑
RDNT
RadNet
3.0444 of 5 stars
$56.73
+1.8%
$55.25
-2.6%
+104.3%$4.19B$1.62B189.1010,288Analyst Forecast
INSP
Inspire Medical Systems
4.9221 of 5 stars
$158.60
-0.6%
$256.53
+61.7%
-48.7%$4.71B$660.91M-288.361,011Positive News

Related Companies and Tools

This page (NYSE:SEM) was last updated on 5/19/2024 by MarketBeat.com Staff

From Our Partners